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Inflammation mediated by antibody-antigen com-
plexes contributes to autoimmune diseases. Mice
deficient in the common Fcg-chain are protected
from IgG-mediated glomerulonephritis and the re-
verse passive Arthus (RPA) reaction and FcR-bearing
macrophages, and mast cells have been assigned
primary roles in these processes. Here we demon-
strate that neutrophil-selective transgenic expres-
sion of the two uniquely human neutrophil Fc gamma
receptors (FcgRs), FcgRIIA and FcgRIIIB, in Fcg-
chain-deficient mice restored susceptibility to pro-
gressive glomerulonephritis and the cutaneous RPA
reaction. FcgRIIIB and FcgRIIA mediated neutrophil
accumulation, whereas FcgRIIA alone promoted or-
gan injury. In a model of soluble immune complexes
deposited within the vasculature, FcgRIIIB was
responsible for neutrophil slow rolling and adhesion
whereas in the cremaster RPA, induced by both vas-
cular and tissue soluble immune complexes, FcgRIIA
predominated. Thus, human FcgRs on neutrophils
serve as molecular links between antibody and im-
munological disease, with FcgRIIA promoting tissue
injury and FcgRIIIB and FcgRIIA displaying special-
ized context-dependent functions in neutrophil re-
cruitment.
INTRODUCTION
Deposition of antigen-antibody complexes in tissues is a hall-
mark of human diseases, from autoimmune disorders and early
transplant rejection to rheumatic fever. IgG-mediated diseases
are produced either by the binding of pathogenic antibody to
self or foreign antigens on host cells or by the deposition of
circulating antigen-antibody complexes in tissue. Cell-surface
receptors that bind IgG-immune complexes (ICs), known collec-
tively as Fcg receptors (FcgRs), play essential roles in diseases
initiated by antibodies (Ravetch and Bolland, 2001; Schmidt
and Gessner, 2005). In particular, mice deficient in the common
g-chain (Fcer1g/) required for expression of the murineactivating FcgRs are protected in acute and progressive glomer-
ulonephritis, autoimmune skin diseases, arthritis, systemic lupus
erythematosus nephritis, and the reverse passive Arthus (RPA)
reaction (Ji et al., 2002; Ravetch and Bolland, 2001; Trcka
et al., 2002). In addition to FcgRs, C5aR binding to complement
C5a activated by ICs may modulate disease pathogenesis by
regulating the balance of FcgR expression and inducing chemo-
kine release (Schmidt and Gessner, 2005). Despite the impor-
tance of FcgRs and complement proteins in IC-mediated inflam-
mation, mechanisms downstream of their activation and the
relevant Fc-bearing cell type involved still remain largely unre-
solved. The present view is that tissue-resident mast cells and
macrophages sense ICs through FcgRs and complement recep-
tors and, subsequently, release inflammatory mediators that re-
cruit effector cells through the well-described multistep process
of endothelial activation, selectin-dependent rolling, and integ-
rin-mediated adhesion (Jancar and Sanchez Crespo, 2005; Ley
et al., 2007; Schmidt and Gessner, 2005).
Neutrophils are key effector cells in innate immune responses,
yet FcgRs specifically on neutrophils have not been implicated
as initial mediators of cellular activation in IgG-disease models
in mice. Given the structural differences between murine and hu-
man low-affinity FcgRs, it is not clear how well studies mediated
by murine receptors accurately reflect human inflammation. Mu-
rine neutrophils express FcgRIII and FcgRIV (Nimmerjahn and
Ravetch, 2006), which are transmembrane receptors relying on
a common immunoreceptor tyrosine-based activation motif
(ITAM)-containing g-chain for expression and signaling. In con-
trast, human neutrophils express a unique glycosyl-phosphati-
dyl-inositol (GPI)-anchored FcgRIIIB and a single-polypeptide
ITAM-containing FcgRIIA for which there are no genetic equiva-
lents in mice or other mammals (Hogarth, 2002). Thus the low-
affinity human receptors are single-polypeptide molecules, with
FcgRIIA containing its own signaling domain, whereas the
murine counterparts function as multiprotein complexes, with
ligand-binding and signaling functions present on separate
polypeptides.
The biological role of the two unique human neutrophil FcgRs,
FcgRIIA and FcgRIIIB, remains largely unclear. Genetic evidence
indicates that polymorphisms in FcgRIIA and IIIB correlate with
autoimmune disease in patients (van Sorge et al., 2003), and
a low gene copy number of FcgRIIIB predisposes systemic lupus
erythematosus patients to glomerulonephritis (Aitman et al.,
2006). In vitro, engagement of FcgRIIA promotes phagocytosis,Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc. 833
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Role of Human Neutrophil FcgRs in InflammationFigure 1. Neutrophil-Specific Expression of Human Fcg Receptors in Transgenic Mice
(A and B) hFcgR expression was evaluated by flow cytometry on Fcer1g/ (dotted line) and IIA,IIIB+Fcer1g/ (solid line) mice. hFcgRIIA and IIIB expression was
analyzed on (A) peripheral-blood neutrophils (Gr-1himCD11b+) and monocytes (mCD115+mCD11b+), and FcgRIIA expression was assessed on (B) F4/80+ resident
peritoneal and bone marrow (BM)-derived macrophages, peritoneal mast cells, CD3+ T cells, and platelets. The percentages of FcgR-positive cells are indicated.
(C) Cell-surface expression of mouse CD11b, hFcgRIIIB, and mouse CD62L (L-selectin) in bone-marrow neutrophils (BMN) from IIIB+ transgenic mice stimulated
without (dotted line) or with 100 ng/ml of PMA for 10 min (solid line). hFcgRIIIB shedding (middle panel) is associated with the CD11b upregulation and L-selectin
shedding, hallmarks of neutrophil activation.834 Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc.
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Role of Human Neutrophil FcgRs in Inflammationdegranulation, and reactive oxygen species (ROS) generation.
FcgRIIIB’s function remains elusive despite its 4- to 5-fold-higher
surface expression compared to FcgRIIA in human neutrophils
(Selvaraj et al., 1988; Unkeless et al., 1995). FcgRIIIB cross-link-
ing induces calcium mobilization and triggers degranulation and
leukotriene release (Crockett-Torabi et al., 1992; Unkeless et al.,
1995). In vitro, human FcgRIIIB preferentially tethers neutrophils
to immobilized ICs under physiological flow conditions (Coxon
et al., 2001; Florey et al., 2007; Luscinskas and Mayadas,
2007), and FcgRIIA, in cooperation with chemokine receptors,
was recently shown to enhance leukocyte adhesion to IgG
bound to activated endothelial cells (Florey et al., 2007).
To examine the relative contribution of the human neutrophil-
activating receptors FcgRIIA and FcgRIIIB in effector responses
to IgG in vivo, we generated transgenic mice that express one or
both of these receptors selectively in neutrophils by using a my-
eloid-restricted human migration inhibitory factor-related protein
8 (hMRP8, S100A8) promoter (Lagasse and Weissman, 1994;
Lagasse and Weissman, 1997). These mice were crossed to
Fcer1g/ mice to eliminate endogenous murine activating re-
ceptors. We show that expression of both FcgRIIA and IIIB in
neutrophils was sufficient to restore disease in Fcer1g/ mice
subjected to a model of progressive glomerulonephritis or
RPA. These are prototypic models of type II and type III autoim-
munity induced by in situ or soluble ICs, respectively. FcgRIIIB
and FcgRIIA promoted neutrophil accumulation in both models,
whereas FcgRIIA alone was required for tissue injury. The ob-
served neutrophil recruitment in the absence of FcgR expression
in macrophages and mast cells suggested a direct role for neu-
trophil FcgRs in neutrophil recruitment. We provide evidence
that FcgRIIA and FcgRIIIB tether to in situ-formed glomerular
ICs and play distinct context-dependent roles in soluble-IC-
induced slow leukocyte rolling, adhesion, and transmigration.
Together, our work suggests a paradigm in human IgG-mediated
diseases wherein neutrophils are recruited and promote tissue
injury through their own FcgRs. Further, our data indicate that
each of the FcgRs specializes in separate steps leading to organ
injury.
RESULTS
Generation of Mice with Neutrophil-Selective
Expression of Human FcgRIIA and FcgRIIIB
and Analysis of Receptor Expression
Human neutrophil FcgRs were placed under the control of the
human MRP8 promoter (Figure S1 available online), which drives
expression primarily in the myeloid lineage (Lagasse and Weiss-
man, 1994). The two human FcgR transgenics, and a third line
generated by breeding mice expressing the single transgenes,
were bred to Fcg-chain-deficient (Fcer1g/) mice to produce
animals that express the activating human FcgRIIA and/or
FcgRIIIB on neutrophils in the absence of endogenous murine
activating FcgRs. These transgenic lines are referred to asIIA+Fcer1g/, IIIB+Fcer1g/, and IIA,IIIB+Fcer1g/. Flow-cy-
tometric analysis revealed that the human proteins were present
on greater than 85%–95% of peripheral-blood transgenic neu-
trophils and on a population of monocytes (FcgRIIA on 20%
and FcgRIIIB on 70% of cells) (Figure 1A). Both receptors were
largely absent on macrophages, mast cells, CD3+ T cells,
platelets (Figure 1B), and B cells (data not shown). PMA stimula-
tion resulted in FcgRIIIB shedding from the surface of activated
transgenic neutrophils (Figure 1C) as reported for human neutro-
phils (Huizinga et al., 1988), indicating similar regulation of the
receptor in transgenic murine and human cells.
The relative expression of the human transgenic versus en-
dogenous mouse FcgRs was determined by quantitation of
mRNA expression in neutrophils expressing FcgRIIA or FcgRIIIB
on a wild-type background. This approach, rather than the anti-
body-mediated detection of protein amount, was pursued be-
cause different antibodies may have differing affinities for their
targets and therefore cannot be directly compared. Importantly,
mRNA transcript expression of the two human FcgR transgenes
and the endogenous murine FcgRIII was similar as detected by
quantitative RT-PCR (Figure 1D). To determine how closely the
degree of expression of human FcgRs on murine neutrophils re-
capitulates that observed in human neutrophils, we compared
human FcgR surface expression in murine transgenic and hu-
man neutrophils by fluorescence-activated cell sorting (FACS)
analysis. Transgenic FcgRIIA protein expression was equivalent,
whereas FcgRIIIB on transgenic neutrophils was reduced
compared to human neutrophils (Figure 1E).
FcgRIIA but Not FcgRIIIB Engagement Results
in the ROS Generation
The contribution of the human FcgRs to IC-mediated adhesion
and the release of ROS was evaluated. Similar numbers of iso-
lated transgenic and wild-type neutrophils adhered to immobi-
lized BSA-anti-BSA ICs. Despite this, the morphology and F-ac-
tin distribution in IIIB+Fcer1g/ neutrophils was altered. That is,
IIA+Fcer1g/, IIA,IIIB+Fcer1g/, and wild-type neutrophils
contained distinct lamellipodia enriched in cortical actin,
whereas these structures were largely absent in IIIB+Fcer1g/
cells (Figure 2A). Adhesion-dependent H2O2 production was
comparable in the wild-type, IIA+Fcer1g/, and
IIA,IIIB+Fcer1g/ but was minimal in the IIIB+Fcer1g/ and
Fcer1g/ neutrophils (Figure 2A and 2B). To bypass any effects
of defective adhesion on ROS generation, we examined FcgR
cross-linking-induced ROS generation in cells in suspension.
FcgRIIA cross-linking on IIA+Fcer1g/ or IIA,IIIB+Fcer1g/
neutrophils resulted in robust ROS generation (Figure 2C). In
contrast, FcgRIIIB cross-linking resulted in minimal ROS gener-
ation in IIIB+Fcer1g/ that was only marginally increased in
IIA,IIIB+Fcer1g/ neutrophils (Figure 2C). FcgRIIA-induced
ROS generation was inhibited with pharmacological inhibitors
of Src, Syk kinase, and phosphatidylinositol 3-kinase
(Figure 2C) and was associated with tyrosine phosphorylation(D) Messenger RNA expression of endogenous mouse FcgRIII (open bar) and transgenic human FcgRs (filled bars) was measured by quantitative RT-PCR in
mouse BMN isolated from wild-type mice (Fcer1g+/+) expressing the IIA or IIIB transgene and reported relative to b-actin. The results are shown as average ± stan-
dard deviation (SD) of n = 4 per group.
(E) Comparison of FcgRs on human PMN (hPMN) and mouse BMNs (mBMN) from IIA,IIIB+Fcer1g/ animals by flow-cytometry analysis. Solid lines indicate stain-
ing for hFcgRIIA or FcgRIIIB; the mean fluorescence intensity is given. Dotted line shows the cell populations stained with isotype IgG control.Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc. 835
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Role of Human Neutrophil FcgRs in InflammationFigure 2. In Vitro Analysis of Neutrophil
Adhesion to Immune Complexes and the
ROS Generation
Neutrophils isolated from bone marrow of the indi-
cated mouse strains were placed on plates coated
with BSA-anti-BSA immune complexes (IC) or
BSA alone. Wild-type mice are denoted as
Fcer1g+/+.
(A) The average number of adherent neutrophils on
IC was quantitated (left). All data are mean ± stan-
dard error of the mean (SEM) of four independent
experiments. Representative pictures of neutro-
phils adherent to immobilized IC for 30 min taken
at low (top) and high (bottom) power are shown
to the right. IIA+Fcer1g/ neutrophils spread
with prominent cortical F-actin (arrow heads),
while IIIB+Fcer1g/ neutrophils failed to do so
and remained retracted.
(B) H2O2 concentration in culture supernatant har-
vested from neutrophils adherent to IC (top panel)
or BSA alone (bottom panel). All data are mean ±
SEM of three or four independent experiments.
(C) Cross-linking induced ROS generation. Upper
panel: neutrophils from indicated mice were prein-
cubated with mouse anti-human FcgRIIA (IV.3) or
anti-FcgRIII (3G8) after GM-CSF priming. Real-
time generation of ROS was monitored upon addi-
tion of F(ab’)2 goat anti-mouse IgG (GAM) via a lu-
minol-based assay. The ROS profile of Fcer1g/
neutrophils after FcgRIIA cross-linking is also
shown as a control. Lower panel: real-time gener-
ation of ROS was evaluated in IIA+ Fcer1g/ neu-
trophils treated with Piceatannol (Syk inhibitor),
PP2 (Src inhibitor), or LY294002 (PI3K inhibitor),
primed with GM-CSF and subjected to FcgRIIA
crosslinking with IV.3. One of three representative
experiments is shown.(data not shown), as is expected for ITAM-based signal trans-
duction (Underhill and Goodridge, 2007). Thus, FcgRIIA engages
the expected ITAM-based signaling machinery in murine neutro-
phils to trigger ROS generation, whereas FcgRIIIB does not link
to this effector response.
Human Neutrophil FcgRs Are Sufficient to Restore
Progressive Glomerulonephritis in Fcer1g/ Mice
Progressive nephrotoxic serum (NTS) nephritis in mice is a proto-
typic type II-hypersensitivity response in the kidney induced by
antibody directed against the glomerular basement membrane
(GBM). Presensitization of mice with rabbit IgG prior to challenge
with rabbit NTS results in glomerular injury and renal dysfunction
that resembles aspects of Goodpasture syndrome in humans
(Neale and Wilson, 1982). NTS-induced renal damage relies on
heterologous (rabbit or sheep) rather than autologous mouse
IgG (Dean et al., 2005; Li et al., 1997; Rosenkranz et al., 1999).
Whereas Fcer1g/ mice subjected to progressive NTS nephritis
failed to develop disease (Figures 3A–3E) as reported (Park et al.,
1998), IIA+Fcer1g/ exhibited mortality, renal dysfunction (ele-
vation of urine albumin and serum creatinine), and histopatho-
logic evidence of significant glomerular and interstitial damage836 Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc.(Figures 3A–3E). Renal injury was absent in IIIB+Fcer1g/
mice (Figures 3A–3E). However, mice expressing both FcgRIIA
and FcgRIIIB exhibited considerably more disease compared
to animals expressing FcgRIIA alone, indicating cooperation be-
tween FcgRIIA and FcgRIIIB. Compared to wild-type animals,
mice expressing IIA, or IIA and IIIB, had earlier onset of disease,
greater disease severity, and ultimately mortality (Figures 3A–
3E). These data suggest a primacy of human neutrophil FcgRs
in glomerular inflammation and pathology.
NTS nephritis is associated with glomerular inflammatory cell
infiltration as a result of antibody deposition (Fries et al., 1988)
and secondary interstitial leukocyte accumulation as a conse-
quence of damage to the glomerulus (Anders et al., 2003). Glo-
merular neutrophil accumulation was minimal in Fcer1g/
mice (Figure 4A), as previously shown (Suzuki et al., 1998). In
contrast, a striking increase in neutrophil influx was observed
in IIA+Fcer1g/ and IIA,IIIB+Fcer1g/ at day 7 after disease in-
duction (Figure 4A). The apparent decrease at later time points
probably reflects the destruction or clearance of neutrophils in
the inflamed tissue. Substantial glomerular neutrophil accumula-
tion was also detected in IIIB+Fcer1g/ mice. However, this was
not accompanied by renal injury in these animals (Figure 3),
Immunity
Role of Human Neutrophil FcgRs in InflammationFigure 3. Analysis of Progressive NTS Nephritis
Mice were preimmunized with rabbit IgG in incomplete Freud’s adjuvant on day 3 and injected intravenously with NTS on day 0. Wild-type mice are denoted as
Fcer1g+/+.
(A) Survival of five different strains of mice after induction of disease. IIA+Fcer1g/ mice (n = 23) and IIA,IIIB+Fcer1g/ mice (n = 8) showed high mortality. All
IIIB+Fcer1g/, Fcer1g/, and Fcer1g+/+ mice (n = 12–16 per group) survived the entire experimental time period.
(B and C) Analysis of renal function. Albuminuria (n = 8–23 per group) (B) and serum creatinine at day 14 (n = 6–11 for each group) (C) were elevated in IIA+Fcer1g/
and IIA,IIIB+Fcer1g/ mice compared to Fcer1g/ and IIIB+Fcer1g/, and disease was accelerated in IIA+Fcer1g/, IIA,IIIB+Fcer1g/ compared to
wild-type mice.
(D) A quantitation of glomerular PAS deposits of indicated strains at day 7 is shown (n = 6–10 per group). All data are mean ± SEM p < 0.001 by ANOVA among all
strains of mice.
(E) Representative pictures of periodic acid-schiff (PAS)-stained sections of kidney harvested on day 21. Deposition of PAS-positive material (indicative of glo-
merular damage), occlusion of the glomerular capillary lumen, and adhesion to Bowman’s capsule, as well as interstitial damage including tubular dilation, severe
tubular cell atrophy, and cast formation, were observed only in IIA+g / mice. The bars represent 200 mm (upper) and 50 mm (lower).
Tukey-Kramer was done for comparison between two mouse strains at 5% significant level. *, versus Fcer1g/ and IIIB+Fcer1g/; #, versus IIA+Fcer1g/; x,
versus C57Bl/6.implying that the recruited neutrophils are not activated. Ele-
vated glomerular neutrophil counts were observed in
IIA,IIIB+Fcer1g/ compared to mice expressing either trans-
gene alone, and this far exceeded that observed in wild-type
mice (Figure 4A). In the renal interstitium, infiltration of neutro-
phils, macrophages, and CD4+ T cells was observed in both
IIA+Fcer1g/ and IIA,IIIB+Fcer1g/ mice (Figures 4B and 4C)
and correlated with the severity of glomerular injury observed
(see Figure 3). Interstitial leukocytic infiltration was minimal in
IIIB+Fcer1g/ (Figure 4B), which correlates with a lack of glo-
merular injury in this group of animals (Figures 3B–3E). CD3+ T
cells and F4/80+ macrophages in renal infiltrates remained neg-
ative for hFcgR expression (data not shown).
Together, the data demonstrate that human neutrophil FcgR
expression is sufficient to restore progressive glomerulonephritis
in Fcer1g/ mice. Both human neutrophil FcgRIIA and the GPI-
linked FcgRIIIB promote glomerular neutrophil accumulation inresponse to in situ-formed glomerular ICs and cooperate in
this activity. However, FcgRIIA alone is responsible for glomeru-
lar injury that results in interstititial macrophage, neutrophil and
T cell accumulation, and associated renal dysfunction. The
enhanced phenotypes in the IIA,IIIB+Fcer1g/ versus wild-type
mice suggest that the human and murine FcgRs are not func-
tionally equivalent.
Human Neutrophil FcgRs Are Sufficient to Restore the
RPA Reaction in Fcer1g/ Mice
Mice were subjected to the cutaneous RPA reaction that is eli-
cited by soluble ICs. Edema and neutrophil accumulation were
reduced in Fcer1g/ mice compared to wild-type mice (Figures
5A and 5B and Figure S2), as previously reported (Sylvestre and
Ravetch, 1994). In contrast, robust edema was observed in
IIA+Fcer1g/ and IIA,IIIB+Fcer1g/ mice and was associated
with significant dermal neutrophil accumulation (Figures 5AImmunity 28, 833–846, June 2008 ª2008 Elsevier Inc. 837
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Role of Human Neutrophil FcgRs in InflammationFigure 4. Analysis of Renal Neutrophil and Macrophage Accumulation in Progressive NTS Nephritis
Wild-type mice are denoted as Fcer1g+/+.
(A) Glomerular neutrophil accumulation was evaluated at the indicated time points (n = 5–14 per group) after induction of progressive NTS nephritis. Represen-
tative pictures of sections with neutrophil-specific esterase stain are shown from day 7 samples. Arrowheads indicate esterase-positive neutrophils. The bar rep-
resents 50 mm.
(B and C) Analysis of interstitial infiltrates of kidneys harvested at the indicated days after NTS injection by FACS analysis of renal single-cell suspensions. Per-
centages of interstitial neutrophils (Gr-1hiF4/80) and monocytes and macrophages (F4/80+) (B) are given. Dotted line indicates baseline levels of infiltrates pres-
ent in nontreated Fcer1g/ mice. In (C), the ratio of CD4+ to CD8+ T cells in renal cell infiltrates and peripheral blood is given. Representative renal sections from
IIA+Fcer1g/ mice immunohistochemically stained for CD4+ and CD8+ T cells revealed significant periglomerular infiltration of CD4+ T cells, whereas CD8+ T
cells were primarily restricted to the interstitium. The bar represents 50 mm. n = 7–14 animals per group. All data are mean ± SEM. Statistics are as described
in Figure 3.and 5B and Figure S2). Mice expressing both human FcgRs ex-
hibited disease indices in excess of wild-type mice. In contrast,
edema was largely absent in IIIB+Fcer1g/ mice despite neutro-
phil accumulation that was comparable to that seen in wild-type
animals (Figures 5A and 5B and Figure S2). Thus, human neutro-
phil FcgR expression in Fcer1g/ mice was sufficient to support838 Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc.the RPA reaction. FcgRIIA and FcgRIIIB mediated neutrophil ac-
cumulation despite the absence of FcgR expression in resident
mast cells, and FcgRIIA elicited tissue injury and together with
FcgRIIIB promoted a RPA reaction that was in excess of that ob-
served in wild-type animals expressing endogenous murine
FcgRs.
Immunity
Role of Human Neutrophil FcgRs in InflammationFigure 5. Analysis of the Reverse Passive
Arthus Reaction
Wild-type mice are denoted as Fcer1g+/+. The re-
verse passive Arthus reaction was induced by the
intradermal administration of anti-OVA antibody
and the intravenous injection of OVA with or with-
out Evans blue dye.
(A) Evans blue in skin was quantitated by blue-dye
extraction in dimethyformamide and measure-
ment of absorbance at OD595.
(B) Neutrophil accumulation in mice not given
Evans blue was assessed on esterase-stained
skin sections harvested 4 hr after disease induc-
tion. Average cell number ± SEM is given. n = 8–11
mice per group. Statistics are as described in
Figure 3.Evidence for Human Neutrophil FcgRIIA and FcgRIIIB
Tethering to Immune Complexes Formed In Situ
A widely held view of antibody-mediated disease is that FcgR-
bearing resident tissue cells promote inflammatory cell infiltra-
tion. Our results indicate that neutrophil FcgRs, in the absence
of FcgR-expressing mast cells and macrophages, support neu-
trophil recruitment after induction of progressive NTS glomerulo-
nephritis and the cutaneous RPA. To explore whether direct
tethering of neutrophil FcgRs to ICs deposited in the vessel
wall promotes neutrophil accumulation, we evaluated the mice
in an acute model of NTS. As with the progressive NTS model,
neutrophil accumulation occurs as a result of antibody binding
to the glomerular basement membrane that is exposed to circu-
lating cells through open fenestrae (Fries et al., 1988; Reeves
et al., 1980). However, in the acute model, NTS delivered in the
absence of IgG presensitization results in rapid, transient glo-
merular neutrophil influx. The relative absence of tissue injury in
the acute model minimizes secondary effects in neutrophil accu-
mulation. Glomerular neutrophil influx was minimal in Fcer1g/
mice (Figure 6), as reported (Coxon et al., 2001; Suzuki et al.,
2003). In contrast, neutrophil recruitment that was observed in
IIIB+Fcer1g/ and wild-type mice peaked at 1 hr after NTS in-
jection. Neutrophil accumulation in IIA+Fcer1g/ was also
prominent at the 1 hr time point, but this was sustained and en-
hanced compared to wild-type and IIIB+Fcer1g/ animals at
time points up to 4 hr after NTS injection. This response was fur-
ther increased in IIA,IIIB+Fcer1g/ mice compared to either of
the single transgenics (Figure 6). These data suggest that neutro-
phil accumulation is supported by neutrophil FcgRIIA and
FcgRIIIB tethering to in situ-formed glomerular ICs.
Differential Contributions of Human Neutrophil FcgRs in
SlowRolling, Adhesion, and Transmigration inModels of
Soluble-IC Deposition
Here we examined the contribution of human FcgRs to neutro-
phil recruitment in response to soluble ICs. For this, two indepen-
dent models of soluble-IC deposition amenable to intravital mi-
croscopy were exploited. In the first model, the RPA was
induced in the cremaster muscle by the intrascrotal injection of
anti-ovalbumin (OVA) and the intravenous delivery of OVA. Neu-
trophil recruitment in this model requires complement and TNF
as well as cellular responses of mast cells, platelets, and acti-
vated endothelial cells (Lister et al., 2007; Norman et al., 2005;Norman et al., 2003). When applied to the skin, the RPA results
in IC deposition within the vessel and in the perivascular and ex-
travascular space (Cream et al., 1971; Jancar and Sanchez
Crespo, 2005). The RPA did not increase the rolling-flux fraction
in wild-type mice (data not shown) but did induce significantly
slower leukocyte rolling velocities and enhanced adhesion and
transmigration compared to animals treated with OVA alone (Fig-
ures 7A–7C). The rolling-flux fraction was similar between wild-
type, transgenic, and Fcer1g/ mice (data not shown). How-
ever, leukocyte rolling velocities were reduced in IIA+Fcer1g/
and IIA,IIIB+Fcer1g/ mice compared to wild-type and
Fcer1g/ animals, suggesting that human FcgRIIA promotes
slow rolling (Figure 7A). The transition to slow rolling in other
models of inflammation is associated with firm arrest (Ley
et al., 2007). Consistent with this, slow rolling was a reliable pre-
dictor of IC-mediated adhesion because the latter was elevated
in IIA+Fcer1g/ and IIA,IIIB+Fcer1g/ mice compared to
Fcer1g/ animals (Figure 7B). Transmigration, which is a time-
dependent variable of adhesion, was also elevated in
IIA+Fcer1g/ and IIA,IIIB+Fcer1g/ mice compared to
Figure 6. Analysis of Neutrophil Influx after Acute NTS Nephritis
Mice were injected with NTS, kidneys were harvested at the indicated time
points, and neutrophil accumulation was enumerated in neutrophil-specific
esterase-stained tissue sections. Wild-type mice are denoted as Fcer1g+/+.
Comparable neutrophil recruitment was observed in wild-type mice and all
three transgenic animals at the 1 hr time point. At later time points, neutrophil
accumulation was further increased in IIA+Fcer1g/ and IIA,IIIB+Fcer1g/
but declined in IIIB+Fcer1g/ and wild-type mice. n = 6–12 per group. All
data are mean ± SEM. Statistics are as described in Figure 3.Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc. 839
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Role of Human Neutrophil FcgRs in InflammationFcer1g/ mice (Figure 7C). G protein-coupled receptors
(GPCRs) play major roles in leukocyte interactions with the ves-
sel wall in non-IC-mediated inflammation models (Ley et al.,
2007). An intravenous injection of pertussis toxin, an inhibitor
of Gai-coupled receptors, prior to the induction of the RPA was
effective as assessed by the inhibition of fmlp-mediated ROS
generation in peripheral-blood neutrophils sampled at the end
of the intravital microscopy procedure (data not shown). Under
these treatment conditions, pertussis toxin completely abro-
gated FcgRIIA-mediated adhesion and transmigration (Figures
7B and 7C) but had no effect on slow rolling (Figure 7A), roll-
ing-flux fractions, or peripheral-blood leukocyte counts (data
not shown). In contrast to FcgRIIA, FcgRIIIB failed to significantly
support neutrophil recruitment because slow rolling and adhe-
sion was not observed in IIIB+Fcer1g/ mice (Figures 7A and
7B). Thus, in this model FcgRIIA cooperates with Gai-coupled re-
ceptors to enhance soluble IC-induced leukocyte adhesion and
transmigration, whereas FcgRIIIB does not significantly partici-
pate in this process.
Next, mice were evaluated after the deposition of preformed
anti-BSA and BSA soluble ICs. In this model, intravenously deliv-
ered ICs rapidly deposit within the vessel wall as a result of
changes in vascular permeability induced by cremaster exterior-
ization (Stokol et al., 2004). IC deposition promotes neutrophil
slow rolling on P selectin and adhesion and transmigration that
are dependent on murine activating FcgRs (Stokol et al., 2004).
Rolling-flux fractions did not increase in mice given preformed
ICs compared to mice given BSA alone as described (Stokol
Figure 7. Intravital Microscopic Analysis of
Neutrophil Recruitment after Deposition of
Soluble ICs
Inpanels (A)–(C), theRPAwas induced inthecremas-
terof the indicated mice by an intrascrotal injection of
anti-OVA followed by an intravenous injection with
OVA.Wild-typemice areFcer1g+/+.Leukocyte rolling
velocity (A), adhesion (B), and transmigration (C)were
evaluated in each group. The same was evaluated in
wild-type mice (Fcer1g+/+) after injection with OVA
alone, and the average is presented as a dashed
line. IIA+Fcer1g/ mice pretreated with pertussis
toxin (+PTx) are indicated. After IC injection,
IIA+Fcer1g/ and IIA,IIIB+Fcer1g/ exhibited
slow rolling, whereas IIIB+Fcer1g/ failed to do so
(A). Compared to Fcer1g/, adhesion (B) and trans-
migration (C) were significantly increased in
IIA+Fcer1g/ and IIA,IIIB+Fcer1g/ but not in
IIIB+Fcer1g/. Representative pictures of a postca-
pillary venule from Fcer1g/, IIA+Fcer1g/, and
IIIB+Fcer1g/ mice with rolling (arrow), adherent
(arrowhead), and transmigrated (asterisk) neutro-
phils are shown. Pertussis toxin pretreatment
(PTx) completely suppressed the adhesion and
transmigration of leukocytes in IIA+Fcer1g/.
In panels (D)–(F), the indicated mice were injected
intravenously with preformed soluble BSA-anti-
BSA ICs, and the cremaster was exteriorized for
intravital microscopy. IIIB+Fcer1g/ mice given
pertussis toxin (+PTx) are indicated. Leukocyte
rolling velocity (D), adhesion (E), and transmigra-
tion (F) were evaluated in each group. The same
was evaluated in wild-type mice after injection
with BSA alone, and the average is presented as
a dashed line. Slow leukocyte rolling (D) and adhe-
sion (E) were observed in Fcer1g+/+ mice injected
with ICs compared to mice given BSA alone,
whereas this behavior was absent in Fcer1g/
mice. After IC injection, IIIB+Fcer1g/ and
IIA,IIIB+Fcer1g/, but not IIA+Fcer1g/, ex-
hibited significant slow rolling (D) and adhesion
(E). Transmigration was prominent in all groups
of animals except Fcer1g/ mice (F). PTx had
no effect on slow rolling, adhesion, and transmi-
gration in IIIB+Fcer1g/ mice. Representative
pictures of neutrophils interacting with postcapil-
lary venules from Fcer1g/, IIA+Fcer1g/, and
IIIB+Fcer1g/ mice are shown.
All data are mean ± SEM. *, p < 0.05, n = 5 per
group.840 Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc.
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animal groups (data not shown). ICs induced slow rolling, adhe-
sion, and transmigration in wild-type mice that were significantly
attenuated in Fcer1g/ mice (Figures 7D–7F), as reported (Sto-
kol et al., 2004). However, in contrast to the cremaster RPA,
FcgRIIIB was solely required for slow rolling, adhesion, and
transmigration in this model because only IIIB+Fcer1g/ and
IIA,IIIB+Fcer1g/, but not IIA+Fcer1g/, supported these pro-
cesses compared to Fcer1g/ animals (Figures 7D–7F, and
see Movies S1–S3). IIA+Fcer1g/ mice had measurable num-
bers of extravascular neutrophils (Figure 7F), suggesting that
the small number of adherent FcgRIIA-expressing neutrophils
efficiently transmigrate. For examination of the potential contri-
bution of GPCRs to FcgRIIIB-mediated neutrophil interactions
with the vessel wall, IIIB+Fcer1g/ mice were pretreated with
pertussis toxin prior to the injection of preformed soluble ICs.
Pertussis toxin had no effect on FcgRIIIB-mediated slow rolling,
adhesion, or transmigration. Thus, under conditions of primarily
intravascular ICs, and in the absence of activation of Gai-cou-
pled receptors, FcgRIIIB specializes in neutrophil recruitment.
DISCUSSION
Our data demonstrate that expression of human FcgRs selec-
tively on neutrophils is sufficient to induce virtually all aspects
of type II and type III autoimmune responses and hence may pro-
vide critical molecular links between antibodies and immunolog-
ical injury. Neutrophils were recruited via FcgRIIA and FcgRIIIB,
and FcgRIIA alone signaled tissue injury. The individual human
neutrophil FcgRs appear to play separate roles in IC-induced
neutrophil recruitment in response to both ICs formed in situ
and soluble ICs deposited in the vessel wall. In the case of solu-
ble ICs, FcgRIIIB specialized in neutrophil interactions in the con-
text of strictly intravascular ICs, whereas FcgRIIA predominated
in the RPA reaction, which is a more complex response induced
by vascular and tissue ICs and GPCR-binding chemokines. In
the case of in situ-generated ICs, FcgRIIIB and FcgRIIA initiated
recruitment while FcgRIIA was required for sustained neutrophil
accumulation. Neutrophil recruitment and organ injury in the
transgenic line expressing the human complement of neutrophil
FcgRs (FcgRIIA and FcgRIIIB) far exceeded that observed in
wild-type mice (FcgRIII and FcgRIV) despite equivalent expres-
sion of the human and murine activating receptors. This provides
evidence that the human and mouse neutrophil FcgRs are not
functionally equivalent and in humans may play a primary role
in initiating IC-mediated diseases.
The greater tissue damage observed in mice expressing the
human FcgRs compared to the murine FcgRs (i.e., wild-type
mice) may be the result of intrinsic differences such as more ef-
fective ITAM-based signal transduction leading to neutrophil cy-
totoxicity (Van den Herik-Oudijk et al., 1995) or a differential ca-
pacity of the human and murine FcgRs to support neutrophil
recruitment to ICs under conditions of limiting amounts of ICs
in vivo. However, we cannot rule out the possibility that extrinsic
factors, such as the relative degree of interactions between the
activating FcgRs with murine FcgRIIB, and/or a potential down-
regulatory role for murine FcgRs in other cell types accounts for
these differences. Implicit in our results is the possibility that the
contribution of neutrophil-expressed murine FcgRs may havebeen underestimated in past studies. This may indeed be the
case because mast cells and FcgRs on macrophages are only
partially responsible for the RPA reaction and progressive NTS
nephritis, respectively (Bergtold et al., 2006; Sylvestre and Rav-
etch, 1996).
Our studies suggest that the fundamental assumptions of the
pathogenesis of hypersensitivity disease may require re-evalua-
tion in the case of human inflammation. Our finding that neutro-
phils are sufficient to promote type II and type III hypersensitivity
requires modification of the current paradigm primarily deduced
from studies in knock-out mice, which suggest that FcgR-ex-
pressing tissue-resident cells initiate IC-mediated inflammatory
reactions (Schmidt and Gessner, 2005). Our finding that human
FcgRs on neutrophils play a primary role in progressive NTS ne-
phritis suggests the possibility that neutrophils, and in particular
FcgRs on neutrophils, may play a dominant role in the pathogen-
esis of IC-mediated glomerulonephritides. This suggests
a broader significance for neutrophils in these conditions than
previously anticipated. Importantly, neutrophils have been docu-
mented in renal biopsies from patients with membranoprolifera-
tive, lupus, and crescentic glomerulonephritis (Camussi et al.,
1980; Hooke et al., 1987; Segerer et al., 2006). Human FcgRs
were also observed in a subpopulation of monocytes in our
transgenic lines. Therefore, FcgRs on monocytes may be re-
quired for the full expression of renal disease. However, it is note-
worthy that Fcer1g/ mice with transgenic re-expression of the
g-chain and thus activating FcgRs in monocytes and macro-
phages, with no detectable expression in neutrophils, continued
to exhibit a 70% decrease in indices of glomerular damage com-
pared to wild-type counterparts (Bergtold et al., 2006). This ar-
gues that FcgR expression in monocytes is not sufficient for dis-
ease induction. Glomerular-injury-associated proteinuria itself,
as well as chemokines secreted by the glomerulus, stimulates
tubular epithelial cells to secrete chemokines that support inter-
stitial leukocyte infiltration (Anders et al., 2003). Our data indicate
that FcgRIIA-mediated glomerular neutrophil recruitment and
proteinuria promote subsequent interstitial influx of macrophage
and T cells, which are effector populations known to contribute
to disease pathogenesis and end-stage renal failure (Duffield
et al., 2005; Hooke et al., 1987; Tipping and Holdsworth, 2006).
FcgRIIA alone was sufficient to mediate immunological injury
in vivo. The demonstration that reconstitution with an FcgR is
critical in disease models shown previously to be dependent
on the g-chain is noteworthy because this ITAM-based adaptor
is also central to the regulation of receptors important in MHC-I
recognition and myeloid cell and platelet activation, raising the
possibility that some of the phenotypes in Fcer1g/ mice may
be attributed to deficiency in signaling through these receptors
(Fodor et al., 2006; Mocsai et al., 2006; Underhill and Goodridge,
2007). The differential cytotoxic activity of the ITAM-containing
FcgRIIA versus the GPI-linked FcgRIIIB is probably related to
a requirement for ITAM-based signal transduction in the genera-
tion of neutrophil effector functions such as ROS generation, as
demonstrated by our in vitro studies of transgenic neutrophils
and published reports on human neutrophils (Underhill and
Goodridge, 2007). Furthermore, overexpression of ITAM-con-
taining human FcgRIIA or FcaRI on monocytes and macro-
phages in wild-type mice has been reported to aggravate arthri-
tis and glomerulonephritis development (Kanamaru et al., 2007;Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc. 841
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to exhibit cytotoxicity in vivo relative to FcgRIIA because it is
shed from the surface of neutrophils accumulated in the inflamed
tissue.
An important finding was that expression of human FcgRs on
neutrophils was sufficient to elicit neutrophil recruitment. This is
a complex process previously attributed to endothelial cell-
adhesion molecule (CAM) upregulation by cytokines released
from activated endothelial cells and/or by other cells within the
vessel wall to which antibody is bound (Nikolic-Paterson et al.,
1994; Norman et al., 2003; Schmidt and Gessner, 2005). The hu-
man FcgR transgenics exhibited significant neutrophil accumu-
lation in tissues despite the absence of these receptors on
mast cells and macrophages, which indicates a primary role
for the FcgRs on neutrophils in IC-induced neutrophil recruit-
ment. FcgRIIA and FcgRIIIB played equivalent roles in initial neu-
trophil recruitment in response to antibody-antigen complexes
within the glomerular capillaries. Given that the ICs are accessi-
ble to circulating neutrophils through open endothelial fenestrae
(Fries et al., 1988), our results strongly suggest that neutrophil
FcgRs directly tether to ICs. The enhanced accumulation in
mice expressing FcgRIIA observed at later time points suggests
an additional role for this receptor in sustaining neutrophil accu-
mulation, perhaps by signaling the release of leukotrienes and
prostaglandins (Jancar and Sanchez Crespo, 2005). Analysis of
mice in intravital models of soluble-IC deposition indicated non-
redundant functions for the two human FcgRs in neutrophil re-
cruitment. FcgRIIIB was specialized for slow rolling and adhe-
sion induced by intravascular soluble ICs in a model where
neutrophil accumulation is independent of complement C3 and
C5, does not require the function of mast cells, and is not asso-
ciated with platelet accumulation or expression of cytokine-in-
ducible endothelial CAMs (Stokol et al., 2004). However, in
a more complex environment of intravascular, perivascular,
and tissue ICs generated by the RPA (Cochrane, 1963; Cream
and Turk, 1971; Movat and Fernando, 1963), FcgRIIA predomi-
nated. FcgRIIA-mediated adhesion and transmigration were de-
pendent on Gai-coupled receptors. We postulate that engage-
ment of GPCR(s) on neutrophils and/or other cell types may
directly or indirectly modulate FcgRIIA-mediated adhesion by af-
fecting its affinity for deposited IgG (Nagarajan et al., 2000) or up-
regulating neutrophil CD18 integrins known to support FcgR
function (Jones and Brown, 1996).
The assignment of an important physiological role for FcgRIIIB
in neutrophil recruitment is significant particularly because the
function of this GPI-anchored receptor remains largely unknown.
Furthermore, our results ascribe a function to FcgRIIIB that
doesn’t require FcgRIIA, a finding unanticipated from previous
work (Unkeless et al., 1995). What is the physiological role of
FcgRIIIB in neutrophil tethering to intravascular ICs? We pro-
pose that FcgRIIIB may clear ICs from the glomerulus, which is
a frequent site of IC trapping, and thus aids in the maintenance
of homeostasis (Nangaku and Couser, 2005). Indeed, glomerular
ICs can trigger a transient accumulation of neutrophils with their
return to the circulation and a complete clearance of the immune
deposits and restoration of the glomerular structural integrity
within 24 hr of IC deposition (Fries et al., 1988). The high density
of FcgRIIIB with a GPI anchor nearly the size of an Ig domain that
could permit it to protrude further than FcgRIIA, its predicted fast842 Immunity 28, 833–846, June 2008 ª2008 Elsevier Inc.mobility in the membrane bilayer (Selvaraj et al., 1988), and its
presence on microvilli (Coxon et al., 2001) coupled with its
weak signaling capacity may suit FcgRIIIB for efficient capture
and internalization of ICs with minimal neutrophil activation.
The higher expression of FcgRIIIB in human versus our murine
transgenic neutrophils predicts a more significant role for this
receptor in IC-induced neutrophil accumulation in humans.
FcgRIIIB is normally present in multiple gene copies that usually
positively correlate with its expression, and a low gene copy
number of FcgRIIIB predisposes to glomerulonephritis in sys-
temic lupus erythematosus (Aitman et al., 2006; Stranger et al.,
2007). We speculate that inefficient FcgRIIIB-mediated recruit-
ment and clearance of ICs under homeostatic conditions may
enhance susceptibility to IC-mediated diseases in patients.
Pathogenic-IC accumulation may increase the local generation
of inflammatory mediators that promote FcgRIIIB shedding, in-
crease the capacity of FcgRIIA to bind ligand and signal, and
thus promote tissue damage.
In summary, our studies in FcgR humanized mouse models
have provided evidence that human FcgR expression on neutro-
phils is sufficient for the initiation of IC-induced inflammatory dis-
ease and thus redefines the currently accepted models of type II
and III autoimmune responses developed in knockout mice.
Neutrophils are recruited via their own FcgRs to ICs with FcgRIIA
and FcgRIIIB playing distinct context-dependent roles in this
process, whereas FcgRIIA alone is responsible for tissue injury.
We anticipate that transgenic mice expressing the human reper-
toire of neutrophil FcgRs will continue to serve as important tools
for investigating the physiological function of the individual re-
ceptors, their signaling capacity, and the mechanisms by which
they promote tissue injury in inflammatory and autoimmune dis-
orders relevant to human disease.
EXPERIMENTAL PROCEDURES
Generation of Human FcgR Transgenic Mice
The 0.95 kb of human FcgRIIA cDNA and 0.7 kb of FcgRIIIB cDNA were subcl-
oned into the BglII site of the hMRP8 promoter (Lagasse and Weissman, 1994).
Natural polymorphisms in FcgRIIA and IIIB have been reported. Of these,
cDNAs encoding FcgRIIIB-NA2 and FcgRIIA-R131 were utilized to generate
the transgenics. FcgRIIA-R131 is a natural variant of FcgRIIA in the human
population that is highly responsive to mouse IgG (van der Pol and van de
Winkel, 1998). Each transgene was released from pUC18-hMRP8 vector by
digestion with HindIII and EcoRI and injected into zygotes from C57Bl/6J
mice. Transgenic mice were generated in the transgenic facility of Brigham
& Women’s Hospital (Boston, MA). A high-expressing founder transgenic
line of FcgRIIA transgenic mice (IIA+) was crossed with Fcer1g/ mice on a
C57Bl/6J-F12 background and bred to be hemizygous for the FcgRIIA trans-
gene and g-chain deficient, as assessed by PCR of genomic DNA and flow-
cytometry analysis. IIIB+Fcer1g/ mice were similarly generated. Mice
expressing both FcgRIIA and FcgRIIIB (IIA,IIIB+Fcer1g/) were generated
by breeding IIA+Fcer1g/ and IIIB+Fcer1g/ mice. Mice were maintained
in a virus- and antibody-free facility at the New Research Building animal hous-
ing facility at Harvard Medical School. Mice used for each experiment were
between 6 and 8 weeks of age and sex matched. The Harvard Medical School
Animal Care and Use Committee approved all procedures in this study.
Isolation and Treatment of Leukocyte Populations
Peripheral blood sampled from the retro-orbital plexus of mice was collected in
ethylene diamine tetra-acetic acid (EDTA)-containing tubes. Human peripheral
neutrophils and murine bone-marrow neutrophils were isolated as previously
described (Coxon et al., 2001; Hirahashi et al., 2006). For the assessment of
FcgR shedding, mouse bone-marrow neutrophils were stimulated with or
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maldehyde. Bone-marrow-derived macrophages were generated by culturing
cells harvested from the tibia and femurs of mice in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% FCS and 20% L929-condi-
tioned supernatant for 5 days. Peritoneal cells for FACS analysis were har-
vested by lavaging the peritoneum with cold PBS and plating for 18 hr on poly-
styrene dishes in 10% FCS in DMEM. For peritoneal mast cells, peritoneal cells
were immediately used for FACS analysis.
Flow-Cytometry Analysis
All antibodies were from BD Biosciences-PharMingen unless otherwise indi-
cated. Human FcgRIIA or FcgIIIB expression on peripheral-blood leukocytes
was characterized by using fluorescein isothiocyanate (FITC) or allophycocya-
nin (APC)-mouse anti-human FcgRIIA (clone FLI8.26, mouse IgG2k) or FITC-
mouse anti-human FcgRIIIB (clone 3G8, mouse IgG1). Cell populations were
identified by PE-rat anti-Gr-1 (Ly-6G and Ly-6C, clone RB6-8C5) for neutro-
phils, PE-rat anti-CD115 (clone AFS98; eBioscience) for monocytes, PE-
Cy7-hamster anti-mouse CD33 (clone 145-2C11) for T cells, APC-rat
anti-mouse CD11b (Integrin aM chain, clone M1/70) for neutrophils and mono-
cytes, and FITC-rat anti-mouse CD62P (RB40.34) for platelets. As a positive
control for receptor shedding, APC-rat anti-mouse CD62L (clone MEL-14)
was used.
For analysis of resident peritoneal and bone-marrow-derived macrophages,
cells were stained with PE-mouse anti-human FcgRIIA or FcgRIII antibody
amd APC-rat anti-F4/80 (clone A3-1; Caltag Laboratories). Mature mast cell
populations were identified with FITC-hamster anti-mouse Fc3RIa (clone
MAR-1; eBioscience) and PE-rat anti-mouse c-Kit (clone 2B8) antibody.
Fc3RIa-negative but c-Kit-positive cells in Fcer1g/ mice with transgenic ex-
pression of human FcgRs and in Fcer1g/ mice were analyzed for human
FcgR expression.
Infiltrating renal neutrophils, macrophages, and T cells were quantitated by
three-color flow cytometry. Single-cell suspensions from individual kidneys
were prepared as described (Vielhauer et al., 2003). For analysis of leukocyte
surface markers, cells were incubated with PE-anti-Gr-1, APC-anti-CD33, or
APC-anti-F4/80. The amounts of positively stained neutrophils (Gr-1hiF4/80)
and macrophages (F4/80+) were expressed as percentage of total renal cells.
Renal cell suspensions were also stained with APC-anti-CD33, FITC-anti-
CD4 (clone RM4-5) and PE-anti-CD8a (clone 53-6.7) to determine the CD4+
to CD8+ ratio in the CD3+ T cell population.
Quantitative Real-Time PCR
Complementary DNAs were synthesized from total RNA of bone-marrow neu-
trophils via a cDNA synthesis kit (Invitrogen). RT-PCR by Taq DNA polymerase
(New England Biolabs) was performed with the following primer sets: mouse
FcgRIIIA (QIAGEN, QT00117803); human FcgRIIA (QIAGEN, QT00042826);
human FcgRIIIB (50-CGTGCTTGAGAAGGACAGTG-30, 50-CTGGCTTGAGAT
GAGGCTCT-30); and mouse b-actin (50-CCTGAGCGCAAGTACTCTGTGT-30,
50-GCTGATCCACATCTGCTGGAA-30). Each RT-PCR product was inserted
into pGEMT-Easy vector (Promega) for a reference standard. Quantitative
real-time PCR on cDNA samples by SYBR green RT-PCR method (Bio-Rad,
Hercules, CA, USA) was conducted with the indicated primer sets. Actual tran-
script levels of mouse FcgRIIIA and human FcgRs genes were determined
against the reference standard made by serial dilution of the pGEMT-Easy
vector containing FcgR templates. The relative expression of each gene was
normalized against b-actin.
Neutrophil Adhesion, F-Actin Staining, and Determination of
Cellular H2O2 Production on IC
Experimental details for adhesion assay and F-actin staining were previously
described (Tang et al., 1997). Adherent cell numbers were quantitated in three
independent fields at magnification 2003, and the average cell number per
field was determined. Neutrophils were plated on glass coverslips coated
with ICs formed by BSA and polyclonal rabbit anti-BSA antibody (Tang
et al., 1997) or BSA alone in 24-well plates. The experimental protocol for
cellular H2O2 production was essentially as described by Werner et al.,
2003 (Werner, 2003), with some modifications. For the indicated time periods
1.03 106 bone-marrow neutrophils from each mouse strain in 1.0 ml of assay
mix solution (100 mM homovanillic acid [Sigma] in HBSS, 5 U/mL horseradishperoxidase type VI [Sigma], and 1 mM HEPES [pH 7.5]) were incubated at
37C. The plate was then centrifuged, and cell-free supernatant was collected
and further incubated at 37C for 1 hr. The reaction was terminated by the ad-
dition of 0.1 M glycine solution. The fluorescence in supernatants was mea-
sured by a fluorometer (excitation 321 nm, emission 421 nm), and the H2O2
concentration in each sample was determined relative to the calibration curve
made by an H2O2 standard.
Human FcgRCross-Linking-Mediated Oxidative Burst in Neutrophils
Bone-marrow neutrophils were incubated with 10 mg/ml mouse anti-hFcgRIIA
(clone: IV.3, StemCell Technologies) or anti-hFcgRIIIB (clone 3G8, Caltag Lab-
oratories) on ice for 30 min. Cells (2.5 3 106/sample) were washed and then
incubated with 1 mg/ml of mouse GM-CSF for 30 min followed by incubation
with or without piceatannol (20 mM, Sigma), PP2 (10 mM, Calbiochem), or
LY294002 (20 mM, Calbiochem) at 37C for 30 min. FcgR cross-linking was ini-
tiated by the addition of goat anti-mouse F(ab’)2 (100 mg/ml, Jackson Immu-
noResearch Laboratories), and ROS generation was continuously monitored
with a luminol-based assay as previously described (Utomo et al., 2006).
Nephrotoxic Serum Nephritis
Experimental nephrotoxic serum (NTS) nephritis was induced in 8-week-old
males as previously reported (Rosenkranz et al., 2000) with the following mod-
ifications. In brief, mice were preimmunized subcutaneously in the right foot-
pad with 0.05 mg rabbit IgG (Jackson ImmunoResearch Laboratories) in
Freund incomplete adjuvant and nonviable desiccated Mycobacterium
tuberculosis H37Ra (Difco, Michigan). Three days later, mice were injected in-
travenously with 50 ml heat-inactivated, filter-sterilized nephrotoxic serum.
Spot urine samples and peripheral blood were collected at indicated time
points after NTS injection. Both kidneys from euthanized mice were harvested
for histological analysis and flow cytometry. Acute NTS nephritis was induced
in 7-week-old male mice by the intravenous injection of 300 ml of nephrotoxic
serum without prior preimmunization.
Functional Assessment of Renal Injury
Urine albumin concentrations and creatinine levels in urine and serum were
determined by ELISA (Rosenkranz et al., 2000) and Creatinine Assay Kit
(Cayman Chemical Company), respectively. Albuminuria was expressed as
mg albumin per mg urinary creatinine to standardize urine albumin excretion
for glomerular filtration rate and urinary concentration.
Histological Assessment of Renal Injury, Renal Neutrophil,
and T Cell Accumulation
The presence of PAS-positive deposits within glomeruli was graded semi-
quantitatively as previously described (Rosenkranz et al., 2000). Glomerular
PMN infiltration was assessed by the chloroacetate esterase reaction as re-
ported (Coxon et al., 2001). For each animal, glomerular neutrophil counts in
more than 100 glomeruli per kidney section were made. For the histological
assessment of T cell accumulation, renal cryostat sections were stained with
unlabeled anti-CD4 (clone RM4-5) or anti-CD8a (clone 53-6.7).
Reverse Passive Arthus Reaction
Rabbit anti-chicken egg albumin IgG (60 mg/30 mL; Cappel, Aurora, OH) or PBS
alone were injected intradermally in the left or right portion of the dorsal skin in
6- to 8-week-old female mice, followed immediately by the intravenous (i.v.) in-
jection of chicken egg ovalbumin (400 mg/mouse; Sigma-Aldrich, St. Louis,
MO). Four hours later, the skin containing the injection site was removed
from euthanized mouse. In cases where edema was measured, the solution
of chicken egg albumin contained 0.15% Evans blue dye (Sigma-
Aldrich). Measurement of Evans blue leakage and neutrophil influx was con-
ducted as described (Utomo et al., 2008).
Intravital Microscopy
Soluble ICs were prepared as previously described (Stokol et al., 2004).
Leukocyte recruitment in cremaster muscle venules was evaluated in mice
within 60 min of a single i.v. injection of ICs or BSA. For the RPA in the scrotum,
rabbit IgG anti-chicken egg albumin antibody (100 mg/100 mL) was injected in-
trascrotally, followed by the i.v. injection of chicken egg ovalbumin (240 mg/240
mL; Sigma-Aldrich, St. Louis, MO). Leukocyte recruitment in the cremaster wasImmunity 28, 833–846, June 2008 ª2008 Elsevier Inc. 843
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4 mg of pertussis toxin (Sigma) 4 hr prior to injection of preformed soluble ICs or
induction of the RPA.
The procedures for preparation of the cremaster of anesthetized mice and
subsequent intravital microscopy were essentially as described (Lauterbach
et al., 2008). Four venules per mouse were analyzed over a 20 min time period.
At the completion of the intravital microcopy experiment, blood was collected
from the retro-orbital plexus to measure total leukocyte counts. Leukocyte roll-
ing velocities were measured by tracking single leukocytes (10/venule) over
several frames and calculating distance moved per unit time (mm/s). Adherent
leukocytes were defined as cells remaining stationary for 30 s and were
expressed as the number of cells/ mm2 of venule. Transmigrated leukocytes
were defined as cells outside of the venule and were expressed as the number
of cells/mm2.
Statistical Analysis
In nephrotoxic anti-GBM nephritis and RPA, data were analyzed by
ANOVA among five strains—Fcer1g/, IIA+Fcer1g/, IIIB+Fcer1g/,
IIA,IIIB+Fcer1g/, and C57Bl/6 mouse—except for day 21 samples, when 4
strains were analyzed because of low survival in IIA,IIIB+Fcer1g/ animals.
Data in which significant difference (p < 0.001) was shown by ANOVA were
subjected to Tukey-Kramer for comparison between two mouse strains at
5% significance. In intravital microscopy, Mann-Whitney U test was used for
analysis, and statistical significance was accepted at p < 0.05.
SUPPLEMENTAL DATA
Two figures and three movies are available at http://www.immunity.com/cgi/
content/full/28/6/833/DC1/.
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